- DKK16.77bn
- DKK16.63bn
- DKK6.04bn
Brief: Ambu Obtains FDA Clearance For Single-Use Therapeutic Gastroscope
Europe Research Roundup: Antofagasta, Rational AG, Spirax-Sarco
Ambu jumps as soaring endoscopy sales drive Q1 beat
Brief: Ambu Maintains 2023/24 Financial Guidance
Brief: Ambu Q1 Adjusted EBIT DKK 126 Million Vs. Estimate DKK 105 Million
Brief: Ambu Obtains CE Mark Of Ureteroscopy Solution
Europe Research Roundup: Anglo American, Marks and Spencer, Vestas
Brief: Ambu Upgrades Its Full-Year EBIT Margin
Brief: Ambu Q4 Adjusted EBIT DKK 97 Million Vs. Estimate DKK 97 Million
Brief: Ambu Outlook FY Adjusted EBIT Margin 8-10%
Brief: Ambu Plans For Integrating Bioplastics Across Its Full Portfolio Of Endoscopes
Brief: Ambu APPOINTS NEW CHIEF FINANCIAL OFFICER
Ambu surges after FDA clearance for 'niche' tool
Brief: Ambu Announces FDA Clearance Of First-Generation Single-Use Colonoscope
Brief: Ambu Announces CE Mark Of Therapeutic Gastroscope
Europe Research Roundup: Beiersdorf AG, Essity AB (Publ), Koenig & Bauer AG
Ambu drops to bottom of STOXX as improved guidance lags consensus
Brief: Ambu Cuts FY Outlook, Now Sees Adj. EBIT Margin at 5-6%
Brief: Ambu Narrows Organic Revenue Growth Guidance Based On Q3, Q4 Performance